Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans

Neuroscience Letters

Volumn 347, Issue 3, 2003, Pages 202-204

  Itokawa, Masanari ^a,b   Arai, Makoto ^a   Kato, Shuhei ^a   Ogata, Yoko ^a,b   Furukawa, Aizo ^c   Haga, Seiichi ^a   Ujike, Hiroshi ^d   Sora, Ichiro ^e   Ikeda, Kazuhiko ^a   Yoshikawa, Takeo ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

485C>T polymorphism; 1128T>C (Leu7Pro) polymorphism; Case control study; IMR 32 cell; Japanese; Luciferase activity

Indexed keywords

NEUROPEPTIDE Y;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPEPTIDE Y GENE; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; GENETIC PREDISPOSITION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUROPEPTIDE Y; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA;

EID: 0042591087     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00718-3     Document Type: Article

References (15)

1. Ding B., Bertilsson L., Wahlestedt C. The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean population. J. Clin. Pharm. Ther. 27:2002;211-212.
2. Drube J., Kawamura N., Nakamura A., Ando T., Komaki G., Inada T. No leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y in Japanese population or Japanese with alcoholism. Psychiatr. Genet. 11:2001;53-55.
3. Frederiksen S.O., Ekman R., Gottfries C.G., Widerlov E., Jonsson S. Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatr. Scand. 83:1991;273-277.
4. Gabriel S.M., Davidson M., Haroutunian V., Powchik P., Bierer L.M., Purohit D.P., Perl D.P., Davis K.L. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol. Psychiatry. 39:1996;82-91.
5. Gottesmann I.I. Schizophrenia Genetics: The Origin of Madness. 1991;Freeman, New York.
6. Hartman D.S., Hertel C. Nerve growth factor-induced differentiation in neuroblastoma cells expressing TrkA but lacking p75NGFR. J. Neurochem. 63:1994;1261-1270.
7. Itokawa M., Yamada K., Yoshitsugu K., Toyota T., Suga T., Ohba H., Watanabe A., Hattori E., Shimizu H., Kumakura T., Ebihara M., Meerabux J.M., Toru M., Yoshikawa T. A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia. Pharmacogenetics. 13:2003;271-278.
8. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
9. Karvonen M.K., Pesonen U., Koulu M., Niskanen L., Laakso M., Rissanen A., Dekker J.M., Hart L.M., Valve R., Uusitupa M.I. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 4:1998;1434-1437.
10. Kuromitsu J., Yokoi A., Kawai T., Nagasu T., Aizawa T., Haga S., Ikeda K. Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Gene Expr. Patt. 1:2001;17-21.
11. Lappalainen J., Kranzler H.R., Malison R., Price L.H., Van Dyck C., Rosenheck R.A., Cramer J., Southwick S., Charney D., Krystal J., Gelernter J. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch. Gen. Psychiatry. 59:2002;825-831.
12. Li B.S., Kramer P.R., Zhao W., Ma W., Stenger D.A., Zhang L. Molecular cloning, expression, and characterization of rat homolog of human AP-2alpha that stimulates neuropeptide Y transcription activity in response to nerve growth factor. Mol. Endocrinol. 14:2000;837-847.
13. Makino K., Kataoka Y., Hirakawa Y., Ikeda A., Yamauchi A., Oishi A.R. A leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y was not identified in the Japanese population. J. Clin. Pharm. Ther. 26:2001;201-203.
14. Mathe A.A. Neuropeptides and electroconvulsive treatment. J. ECT. 15:1999;60-75.
15. Sakai K., Maeda K., Chihara K., Kaneda H. Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats. Neuropeptides. 29:1995;157-161.